← Leaderboards
Matthew Desantis
Leidos Biomedical Research, Inc.
$4,447,664
Attributed
$4,447,664
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,447,664 · 1
By mechanism
N01$4,447,664 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ethan Dmitrovsky$597,515,186
- Lynn Briscoe$495,968,635
- Ralph Parchment$197,348,011
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsDatabasesCommunitiesCancer DetectionCancer ImagingClassificationClinical DataClinical ResearchClinical Trials NetworkData AccessData CommonsData SetData SourcesData WarehouseDiagnosisFundingGenomicsGrantHistopathologyImageImaging ProgramLabelLesionMetadata